Manufacturer-Direct GLP-1s 2026
For two years the received wisdom was that brand-name GLP-1s cost well over $1,000 a month, so compounded versions were the only affordable route. That is no longer true. Eli Lilly and Novo Nordisk now sell their own FDA-approved medication directly to patients — Zepbound from $299 a month and Wegovy or Ozempic from $149 — which is close enough to compounded pricing that the trade-off has genuinely changed. This guide covers how the direct route works, what it costs, and where the fine print bites.
The Quick Answer
For semaglutide, NovoCare Pharmacy at $149/month for the pill is the cheapest FDA-approved GLP-1 available anywhere. For tirzepatide, LillyDirect at $299–$449 for Zepbound. Both are pharmacies rather than clinics, so you need a prescription — if you do not have one, Amazon One Medical bundles the prescriber, the pharmacy and same-day delivery at the same price points.
Before paying cash at all, check whether insurance will cover you. An approved prior authorization can bring a brand-name GLP-1 to a $25 copay, which beats every price on this page. See our provider rankings for the insurance-first programmes.
Our Picks, Ranked
NovoCare Pharmacy
Novo Nordisk direct — Wegovy and Ozempic pills from $149/month
Novo Nordisk's own pharmacy holds the lowest published cash price for any FDA-approved GLP-1: $149/month for the Wegovy or Ozempic pill at the starting dose, and $199 for pens. Pill pricing steps up with dose — $149 at 1.5mg, $199 at 4mg, $299 at 9mg and 25mg — so budget for the maintenance dose rather than the first one. The $199 pen rate is an introductory offer covering two monthly fills through December 31, 2026, after which Wegovy runs $349/month and Wegovy HD 7.2mg $399. Insured patients may pay as little as $25/month for up to three months, capped at $100/month in savings and excluding government beneficiaries. Free home delivery, with pharmacy pickup available.
Pricing: Pills from $149/month, pens from $199/month self-pay; as little as $25/month with eligible insurance
Pros
- $149/month is the lowest published cash price for an FDA-approved GLP-1
- Pill and pen formats for both Wegovy and Ozempic
- Free home delivery, with pharmacy pickup also available
- Insured patients may pay as little as $25/month for up to 3 months
Cons
- Pill pricing doubles as you titrate — $149 at 1.5 mg rises to $299 at 9 mg and 25 mg
- The $199 pen price is an introductory offer for 2 fills through December 31, 2026, then $349–$499/month
- Semaglutide only — no tirzepatide, so no Zepbound or Mounjaro equivalent
- No clinicians of its own; you must bring or arrange a prescription
Eli Lilly's pharmacy is the only route to Zepbound single-dose vials, which are exclusive to LillyDirect self-pay. Pricing runs $299/month at 2.5mg, $399 at 5mg and $449 for 7.5mg through 15mg under the Zepbound Journey Program — but that maintenance rate is conditional on refilling within 45 days of your previous delivery. Miss the window and you pay $499 at 7.5mg or $699 at 10mg and above, a $250/month swing for being late. The KwikPen adds free retail pickup at Walmart Pharmacy, and commercially insured patients may pay as little as $25 for up to a three-month single-dose pen prescription. LillyDirect also carries Mounjaro and the Foundayo orforglipron tablet.
Pricing: Zepbound self-pay $299–$449/month by dose; $25 for up to 3 months on eligible commercial insurance
Pros
- Authentic FDA-approved medicine straight from the manufacturer — no compounding question
- Full self-pay price list published by dose and device format
- Single-dose vials are exclusive to LillyDirect self-pay
- Free home delivery, plus free Walmart Pharmacy pickup for the KwikPen
Cons
- The $449/month maintenance price requires refilling within 45 days — otherwise $499–$699 applies
- No clinicians of its own; you must bring a prescription or use an independent telehealth partner
- Vial and KwikPen self-pay pricing excludes insurance — spending does not count toward your deductible
- The $25 insured pen offer excludes Medicare, Medicaid, TRICARE and other government beneficiaries
Amazon One Medical
Prescriber, pharmacy and same-day delivery in one place
The manufacturers' pharmacies do not employ clinicians, which is their main limitation. Amazon closes that gap by owning the whole chain: One Medical clinicians run the visits, Amazon Pharmacy fills the script, and delivery is same-day in nearly 3,000 cities. Cash-pay oral Wegovy and Foundayo start at $149/month — matching NovoCare — and injectables at $299, matching LillyDirect. Most major insurance is accepted for visits, manufacturer coupons apply automatically at checkout, and no One Medical membership is required. The catch: the 24/7 on-demand track only renews existing prescriptions, so starting fresh means the full primary-care programme.
Pricing: Oral GLP-1s from $149/month cash or $25/month insured; injectables from $299/month cash
Pros
- Clinician, pharmacy and delivery are all under one roof
- Same-day delivery in nearly 3,000 cities, expanding to 4,500 by the end of 2026
- Transparent pricing shown before you book the appointment
- Manufacturer coupons applied automatically at checkout
Cons
- The 24/7 on-demand track renews existing prescriptions only — new starts need the full program
- Brand-name only, so there is no lower-cost compounded route
- Visit fees ($29 message, $49 video for renewals) are separate from medication cost
- Copays and deductibles still apply on insured visits
The Virtual NP
$75 visit, brand-name only, one nurse practitioner across 7 states
If you want manufacturer-direct pricing but have no prescriber, this is a clean way in. The Virtual NP charges $75 for a weight loss visit with a board-certified nurse practitioner, prescribes only FDA-approved medication from Lilly and Novo Nordisk, and actively routes patients toward NovoCare and LillyDirect savings programmes rather than selling a marked-up product. HSA and FSA are accepted. The constraint is reach — seven states only: Texas, Florida, Nevada, New York, Arizona, New Mexico and Kansas.
Pricing: $75 weight loss visit; FDA-approved medication paid separately via manufacturer pharmacy
Pros
- FDA-approved medication only — no compounded product
- $75 weight loss visit with HSA and FSA accepted
- Actively routes patients to NovoCare and LillyDirect savings programs
- Broad medication list including off-label options when clinically appropriate
Cons
- Only seven states: TX, FL, NY, AZ, NV, NM and KS
- Brand-name pricing is far above compounded alternatives even with savings programs
- Medication is paid separately after approval — the $75 covers the visit only
- A single clinician limits scheduling availability
knownwell
Insurance-based obesity medicine with real clinics, not just video
Manufacturer-direct is a cash-pay play. If your insurance might actually cover a GLP-1, that beats every self-pay price on this page — copays can run as low as $25. knownwell is in network with Aetna, Blue Cross Blue Shield, Cigna, Medicare and United Healthcare, publishes flat self-pay visit rates ($299 first visit, $149 follow-up) if you are not covered, and carries an unusually broad brand-name list including the Foundayo pill. It also notes that Medicare patients must use NovoCare or LillyDirect specifically to access manufacturer discounts.
Pricing: Covered by most major insurance; self-pay $299 first visit, $149 follow-up
Pros
- In network with Aetna, Blue Cross Blue Shield, Cigna, Medicare and United Healthcare
- Flat self-pay visit pricing published: $299 first visit, $149 follow-up
- No sign-up fees and no membership dues
- Very broad brand-name list including the Foundayo (orforglipron) pill
Cons
- Out-of-pocket medication prices are not published — only visit prices
- No compounded option, so cost depends heavily on insurance approval
- In-person care is limited to California, Georgia, Illinois, Massachusetts and New York
- Primary care is limited to the Plano, Texas location
Side-by-Side Comparison
| Provider | Rating | Pricing | Best for |
|---|---|---|---|
| NovoCare Pharmacy | 9.2/10 | Pills from $149/month, pens from $199/month self-pay; as little as $25/month with eligible insurance | Anyone who wants FDA-approved semaglutide at the lowest published cash price, especially in oral form |
| LillyDirect | 9.3/10 | Zepbound self-pay $299–$449/month by dose; $25 for up to 3 months on eligible commercial insurance | Patients who want the FDA-approved brand at the lowest published cash price and already have — or can get — a prescription |
| Amazon One Medical | 8.6/10 | Oral GLP-1s from $149/month cash or $25/month insured; injectables from $299/month cash | Patients who want brand-name GLP-1 care handled end to end, with fast delivery and insurance actually used |
| The Virtual NP | 7.9/10 | $75 weight loss visit; FDA-approved medication paid separately via manufacturer pharmacy | Patients in its seven states who want brand-name medication and a real clinical relationship rather than a compounded subscription |
| knownwell | 8.4/10 | Covered by most major insurance; self-pay $299 first visit, $149 follow-up | Patients with commercial insurance or Medicare who want obesity care inside real primary care, not a prescription-only service |
Prices are self-pay rates published by each provider and were verified against their own pages in August 2026. Manufacturer savings programmes carry eligibility terms and can change without notice.
What manufacturer-direct actually means
LillyDirect and NovoCare Pharmacy are not telehealth companies. They are pharmacies operated by the drug makers themselves, selling the same FDA-approved product that reaches retail pharmacies — just without the distribution layers that add cost.
The practical consequence is that the compounding question disappears entirely. There is no 503A pharmacy to vet, no question about purity or potency, no uncertainty about whether the FDA has reviewed the finished product. You are buying the drug that went through the clinical trials.
What you do not get is a clinician. Both pharmacies require a prescription from somewhere else — your own doctor, or an independent telehealth provider they link to but do not employ. That is the one genuine friction in the direct route.
The reseller markup, in numbers
This is the single most expensive thing to get wrong when buying a GLP-1. Several telehealth platforms resell brand-name medication at multiples of the manufacturer's own price, for a product that is identical in every respect.
- Zepbound: $299–$449/month at LillyDirect · $1,249 at altRx · $1,498 at OrderlyMeds
- Wegovy: $149–$199/month at NovoCare · $1,579 at altRx · $1,599 at Lemonaid · $1,839 at OrderlyMeds
- Ozempic: $149–$199/month at NovoCare · $1,149 at altRx · $1,199 at Lemonaid
A reseller is selling you convenience and a prescriber, not a different medicine. A $75 telehealth visit buys the prescription; the rest of that gap buys nothing. If a platform quotes you four figures for brand-name medication, close the tab and check the manufacturer's price first.
Where the fine print bites
LillyDirect's 45-day refill rule. The $449/month maintenance price for 7.5mg and above applies only when you refill within 45 days of your last delivery. Fall outside it and the price jumps to $499 or $699 depending on dose. Set a reminder — this is a $250/month mistake.
NovoCare's introductory pen pricing expires. The $199 pen rate covers two monthly fills through December 31, 2026. After that Wegovy is $349/month (or $399 for Wegovy HD 7.2mg) and Ozempic $349 to $499. The pill pricing is not introductory, but it does climb with dose.
Self-pay does not touch your deductible. Lilly states plainly that money spent through self-pay savings does not count toward out-of-pocket limits. If you are likely to hit your deductible anyway, running the medication through insurance may be worth more than the lower cash price.
Government beneficiaries are excluded from the $25 commercially insured savings offers — Medicare, Medicaid, TRICARE, VA and similar. Medicare patients should look at the Medicare GLP-1 Bridge programme instead.
Direct versus compounded: how to decide
The honest comparison has narrowed but not disappeared. Compounded semaglutide still starts lower — $79 to $99 a month at yourEra, Trimi Health and Cora Health, against $149 direct from Novo Nordisk. Compounded tirzepatide runs $125 to $179 against $299 at LillyDirect.
So the question is what that difference buys. Going direct means an FDA-approved finished product, no pharmacy to vet, and no exposure to the FDA enforcement activity that has swept this sector. Going compounded means saving roughly $50 to $170 a month and accepting a product the FDA has not reviewed, from a pharmacy that many platforms will not name.
For a lot of people that gap is now small enough that direct wins. If you do choose compounded, our compounded provider rankings are ordered by exactly how much each one discloses.
Frequently Asked Questions
Can I buy Zepbound or Wegovy without a doctor?
No. Both are prescription medications, and LillyDirect and NovoCare are pharmacies rather than clinics — they fill prescriptions, they do not write them. You need a prescriber, whether that is your own doctor, an independent telehealth provider, or a service like Amazon One Medical that bundles both.
Is LillyDirect cheaper than compounded tirzepatide?
Not quite, but the gap is small now. LillyDirect runs $299–$449/month for Zepbound against roughly $125–$279 for compounded tirzepatide. What the extra buys is the FDA-approved finished product rather than a compounded preparation the FDA has not reviewed.
Why do telehealth companies charge over $1,000 for the same drug?
Because they can, and because most patients do not know the manufacturer sells direct. The product is identical — altRx lists Zepbound at $1,249 and OrderlyMeds at $1,498, while Lilly sells it at $299–$449. Always check the manufacturer's own price before buying brand-name medication anywhere else.
Does manufacturer-direct pricing work with insurance?
Partly, and it varies by product. LillyDirect's single-dose vial is self-pay only, while the single-dose pen accepts insurance and carries a $25 savings offer for eligible commercially insured patients. NovoCare offers both tracks. Self-pay spending does not count toward your deductible, which is worth weighing if you have significant medical costs.
What is the cheapest FDA-approved GLP-1?
The Wegovy or Ozempic pill from NovoCare Pharmacy at $149/month for the starting dose. That is the lowest published cash price for any FDA-approved GLP-1, though it rises to $299/month at the highest pill doses.
Medical Disclaimer: This guide is for educational and comparison purposes only and is not medical advice. Rx Saver Hub is not a medical provider and does not prescribe medication. Compounded medications are not FDA-approved, and the FDA does not evaluate their safety, effectiveness or quality. Rankings reflect our editorial assessment of publicly available information, including how much each provider discloses about pricing, pharmacies and clinical process. Always consult a qualified healthcare provider before starting, stopping or changing any weight-loss treatment. Individual results vary.